RN7SL718P

Across TCGA pan-cancer cohorts, RN7SL718P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL718P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RN7SL718P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL718P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

KIRP, SKCM, and STAD are the cancer types where RN7SL718P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.132	0.772	<.001	72	view →
SKCM	OS	Tertile	IV	0.224	0.670	.001	51	view →
STAD	OS	Quartile	IV	0.774	0.217	.003	43	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	42	view →
PAAD	OS	Tertile	All	0.207	0.481	.009	27	view →
THCA	DFS	Tertile	IV	0.572	0.884	<.001	27	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
UCS	DFS	Tertile	III,IV	0.146	0.439	.034	18	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
CESC	DFS	Tertile	IV	0.053	0.529	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL718P–KIRP (OS)

Open the KIRP breakdown →